STP 2022 -- In an effort to better align the positioning of clinical pathology findings in reports and regulatory documents amongst the global clinical pathology toxicologic pathology community, this European Society of Toxicologic Pathology (ESTP) Working Group was formed to discuss the inconsistent utilization of terms such as "biological relevance" and

STP 2022 -- Sprague Dawley (SD) rats are commonly used in toxicologic pathology studies and frequently the rodent choice for two-year (104-week) carcinogenicity studies. It is important to accurately identify rare and common spontaneous neoplasms for proper assessment of the carcinogenic potential of the test article in such studies.

STP 2022 -- Historical control data are important tools used in toxicologic pathology for the evaluation and interpretation of neoplastic and nonneoplastic findings reported during rodent carcinogenicity studies.

Large clinical trials demand experience managing complex organizational requirements to synchronize many moving parts. In the past, Labcorp Drug Development has successfully conducted 14 global mega-trials involving cardiovascular outcomes.

Biopesticide products are becoming increasingly important as part of integrated pest management programs during a crop's life cycle.

Your drug candidate has potential to become the next medical breakthrough. When your studies need support in overcoming operational challenges, we can scale our customizable staffing service to best fit your needs and budget.

For some patients living with cancer, clinical trials may provide new treatment avenues when they fail to respond to standard of care treatment or experience recurrence of their cancer after treatment.

Labcorp's clinical data management teams have conducted over 2,000 studies as part of full-service or standalone clinical contracts since 2008.

UKEMS 2022 -- The ToxTracker® Assay is a panel of mouse embryonic stem cells (mES) with pathways tagged via green fluorescent protein (GFP) such that the biological reactivity and potential carcinogenic properties of novel substances can be identified. The panel of biomarkers was established following extensive genome-wide transcription profiling.